Wednesday, 8 July 2020

α ℓ ℓ ι є ѕ ƒ ι η тє¢нѕ¢σρє's Post

Economic Times



Business Standard

Ø Deutsche-led group exits race for GVK’s power plant

Ø Equalisation levy deadline may not be extended

Ø FM asks heads of 23 CPSEs to boost capex plans

Ø U.S. hiring races to record high in May, layoffs abate

Ø U.S. firms in India may not be ready to pay digital tax

Ø Sebi may allow futures trade in petrol, diesel

Ø Sebi extends compliance deadline for municipal bonds



Ø India's Sovereign Pharma dispatches first batch of remdesivir to Cipla

Ø YES Bank files prospectus with RoC to raise up to Rs 15,000 cr via FPO

Ø PE investments drop 65% to $1.45 billion in June quarter: Refinitiv data

Ø AIIB extends $50 mn loan to L&T Infra Finance for Renewable Energy

Ø Tata Power subsidiary completes sale of three ships for $212.76 million



Business Line



Mint

Ø Adani Ports to raise $1.25 billion through dollar bonds to part-fund Krishnapatnam deal

Ø UltraTech Cement sells Chinese arm for ₹900 crore

Ø ECLGS: Loan sanctioned touch ₹1.14-lakh crore

Ø CG Power’s current debt default at ₹1,023 cr

Ø IL&FS case: SEBI can increase penalties imposed on India Ratings, rules SAT

Ø BP to invest $70 million in Green Growth Equity Fund



Ø Sitharaman asks CPSEs to meet capex target of ₹1.65 lakh cr to fuel growth

Ø Sebi tightens norms for advisers, restricts use of terms like IFAs

Ø India Inc's earnings may see sharp spike in downgrades post Q1

Ø Indian pharma compliance standards improving, regulatory risks here to stay: Ind

Ø Amazon India unit gets fresh fund infusion of ₹2,310 crore from parent



Financial Express



Deccan Chronicle

Ø China’s forex reserves expand in June to over USD 3 trillion

Ø Covid to push share of stressed debt to 18.2% from 11.6%: India Ratings

Ø SC grants interim bail to Unitech promoter Sanjay Chandra

Ø Infosys brings back 200 employees, their families from US; vacates its largest international market



Ø India reviewing around 50 investment proposals from Chinese firms

Ø Mylan Pharma to launch remdesivir in India at Rs 4,800 per 100 mg vial

Ø WB, India sign Rs 5,600 crore support to COVID-19 hit MSMEs

Ø Court grants relief to Hindustan Unilever over 'Glow & Handsome' trademark
By: via α ℓ ℓ ι є ѕ ƒ ι η тє¢нѕ¢σρє

AlliesFinServe #StockMarket #Bharat Telegram.me/AlliesFin's Post

Fund Houses Recommendations Citi on Reliance Ind: Upgrade to Outperform on Company, target price at Rs 1530/Sh (Positive) Jefferies on M...